Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

mHealth Intervention to Prevent Postpartum Depression and Anxiety in Chilean Women (WWWT)

8 maja 2026 zaktualizowane przez: Soledad Coo Calcagni, Universidad del Desarrollo

WHAT WERE WE THINKING" (WWWT) PROGRAM: A DIGITAL INTERVENTION TO PREVENT POSTPARTUM DEPRESSION AND ANXIETY IN CHILEAN WOMEN

The goal of this clinical trial is to evaluate the effectiveness of a digital psychoeducational intervention, "What Were We Thinking" (WWWT), to prevent the development of postpartum depression and anxiety symptoms in first-time mothers in Chile. The study includes adult women with a healthy, full-term infant younger than two months who are receiving care in primary health centers.

The main questions it aims to answer are:

  • Does participation in the WWWT intervention reduce depressive and anxiety symptoms at 3 months after the end of the intervention compared to usual care?
  • Does participation in the intervention improve maternal self-efficacy, perceived social support, and coparenting relationship quality compared to usual care? Researchers will compare an experimental group receiving the full WWWT intervention with a control group receiving usual care to determine the effectiveness of the intervention.

Participants will:

  • Complete self-report questionnaires assessing depressive symptoms, anxiety symptoms, maternal self-efficacy, perceived social support, and coparenting at baseline and at 3-month follow-up
  • Be randomly assigned to either the intervention group or the control group
  • Receive the WWWT intervention between 4 and 10 weeks postpartum (intervention group), including:

    • Fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks
    • Individual contact with a trained facilitator through text messaging
    • One virtual group session with other mothers and a facilitator
  • Continue receiving usual care in primary health services (control group) and receive a shortened version of the intervention after the follow-up assessment

Przegląd badań

Szczegółowy opis

Postpartum depression and anxiety are common mental health conditions that affect women during the transition to motherhood and have significant consequences for maternal well-being, parenting, and infant development. In Chile, a substantial proportion of women report elevated depressive and anxiety symptoms during the postpartum period. Despite the implementation of universal screening strategies in primary health care, access to mental health treatment remains limited, as many women identified as at risk do not engage in or receive appropriate care. This gap highlights the need for preventive interventions that can be delivered early and at scale.

Preventive psychosocial interventions targeting modifiable risk factors, such as maternal self-efficacy and perceived social support, have shown effectiveness in reducing the risk of developing postpartum mental health difficulties. However, engagement in face-to-face interventions is often low. In this context, digital health (e-mental health) and mobile health (mHealth) interventions offer a promising alternative, particularly in settings with high mobile phone access and limited mental health resources. Guided digital interventions that include human support have demonstrated higher adherence and effectiveness compared to unguided formats.

"What Were We Thinking" (WWWT) is a psychoeducational, preventive intervention originally developed in Australia to reduce the risk of postpartum depression and anxiety among first-time mothers. The intervention targets key modifiable risk factors, including maternal self-efficacy in infant care and the quality of partner support. The program has been culturally adapted for use in Chile and further adapted to an mHealth format to facilitate delivery through mobile phones.

The Chilean mHealth version of WWWT includes three main components: (1) fourteen brief psychoeducational video modules (3-5 minutes each) delivered via text messaging over a period of 4 to 5 weeks, each accompanied by reflective prompts; (2) asynchronous communication with a trained facilitator through text messaging to provide guidance, answer questions, and support engagement; and (3) one virtual group session with other participating mothers led by the facilitator. The intervention is delivered between 4 and 10 weeks postpartum. Facilitators are trained health professionals (e.g., psychologists, midwives, nurses) with knowledge in perinatal mental health, and they are also responsible for referring participants to primary care services when needed.

A previous feasibility study conducted in Chile demonstrated high acceptability and feasibility of the mHealth WWWT intervention, as well as positive perceptions among participants regarding its usefulness for maternal well-being and partner involvement. Preliminary findings suggested that the intervention may be particularly beneficial for women presenting with mild symptoms at baseline, consistent with its preventive focus. However, no significant differences were found between intervention and control groups in overall symptom levels, possibly due to elevated baseline distress during the COVID-19 pandemic. Therefore, further research is needed to evaluate the effectiveness of the intervention under non-crisis conditions and in a larger sample.

The present study is a randomized controlled trial with two parallel arms (intervention and control) designed to evaluate the effectiveness of the WWWT intervention in preventing postpartum depression and anxiety symptoms. Participants are first-time mothers with infants younger than two months receiving care in primary health centers in Chile. After baseline assessment, participants are randomly assigned (1:1) to either the intervention group, which receives the full WWWT program, or the control group, which receives usual care. Follow-up assessments are conducted 3 months after completion of the intervention.

Primary outcomes include depressive and anxiety symptoms. Secondary outcomes include maternal self-efficacy, perceived social support, and coparenting relationship quality. Outcomes are assessed using validated self-report measures administered online at baseline and follow-up.

This study will provide rigorous evidence on the effectiveness of a scalable, culturally adapted digital preventive intervention for postpartum mental health in a Latin American context. Findings may inform the integration of mHealth interventions into primary health care services and contribute to improving maternal mental health and early child development outcomes.

Typ studiów

Interwencyjne

Zapisy (Szacowany)

220

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

  • Nazwa: Soledad Coo, PhD
  • Numer telefonu: +56 9 9075 3976
  • E-mail: scoo@udd.cl

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

  • Dorosły
  • Starszy dorosły

Akceptuje zdrowych ochotników

Nie

Opis

Inclusion Criteria:

  • First-time mothers (primiparous women)
  • Aged 18 years or older
  • Having a healthy, full-term infant younger than 2 months of age
  • Receiving prenatal or postnatal care at participating primary health centers in Chile
  • Having access to a mobile phone capable of receiving calls and text messages
  • Able to understand and communicate in Spanish

Exclusion Criteria:

  • Severe symptoms of depression or anxiety at baseline requiring immediate specialized mental health treatment
  • Severe psychosocial problems (e.g., substance abuse, domestic violence, significant cognitive impairment)
  • Infant born preterm or with severe medical conditions (e.g., genetic disorders or serious neonatal complications)
  • Inability to provide informed consent or participate in study procedures due to language or cognitive barriers

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Zapobieganie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Brak (otwarta etykieta)

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: WWWT Intervention
Participants receive the full "What Were We Thinking" (WWWT) mHealth intervention between 4 and 10 weeks postpartum. The intervention includes 14 psychoeducational video modules delivered via text messaging over 4-5 weeks, asynchronous support from a trained facilitator via text messages, and one virtual group session. Participants also continue receiving usual primary health care.
The "What Were We Thinking" (WWWT) is a psychoeducational, preventive mHealth intervention designed for first-time mothers to reduce the risk of postpartum depression and anxiety. The intervention targets modifiable risk factors, including maternal self-efficacy in infant care and perceived social support. It is delivered between 4 and 10 weeks postpartum and includes three components: (1) fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks, accompanied by reflective prompts; (2) asynchronous support from a trained facilitator via text messaging; and (3) one virtual group session led by the facilitator. Facilitators are trained health professionals and can refer participants to primary care services when needed.
Brak interwencji: Usual Care
Participants receive usual care provided by primary health services. They do not receive the WWWT intervention during the study period. After completion of the follow-up assessment, participants are offered a shortened version of the intervention.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Postpartum depressive symptoms
Ramy czasowe: Baseline and 3 months after completion of the intervention
Depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS)
Baseline and 3 months after completion of the intervention
Postpartum anxiety symptoms
Ramy czasowe: Baseline and 3 months after completion of the intervention
Anxiety symptoms assessed using the Depression, Anxiety and Stress Scales (DASS-21)
Baseline and 3 months after completion of the intervention

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Maternal self-efficacy
Ramy czasowe: Baseline and 3 months after completion of the intervention
Maternal self-efficacy assessed using the Escala de Evaluación Parental (EEP)
Baseline and 3 months after completion of the intervention
Perceived social support
Ramy czasowe: Baseline and 3 months after completion of the intervention
Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS)
Baseline and 3 months after completion of the intervention
Satisfaction with coparenting
Ramy czasowe: Baseline and 3 months after completion of the intervention
Satisfaction with coparenting assessed using the Escala de Evaluación Parental (EEP)
Baseline and 3 months after completion of the intervention

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

1 maja 2026

Zakończenie podstawowe (Szacowany)

31 sierpnia 2026

Ukończenie studiów (Szacowany)

31 sierpnia 2026

Daty rejestracji na studia

Pierwszy przesłany

8 maja 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

8 maja 2026

Pierwszy wysłany (Rzeczywisty)

14 maja 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

14 maja 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

8 maja 2026

Ostatnia weryfikacja

1 kwietnia 2026

Więcej informacji

Terminy związane z tym badaniem

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Opis planu IPD

De-identified individual participant data (IPD) will be shared upon reasonable request after publication of the primary study results. Data that may be shared include participant-level outcome data, baseline characteristics, and study-related variables. Identifiable information will be removed to ensure confidentiality. Requests for data access will require approval by the principal investigator and may be subject to a data sharing agreement. Data will be made available for academic research purposes only.

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Badania kliniczne na Lęk poporodowy

Subskrybuj